Looking Towards the Future of CAR T-cell Trials
Delivering the same safe product to a patient while improving timelines of clinical trials
Video Player is loading.
The panelists explain how they hope CAR T-cell clinical trials will improve over time. Tactics like developing scalable manufacturing techniques, having adaptive manufacturing, streamlining regulatory approval, and gaining early feedback from regulatory bodies will help quicken clinical trial processes.
Recent Videos
Final Thoughts
Patient Selection and Recruitment for Clinical Trials
Collaboration with Clinical Trial Sites
Site Selection for CAR T-cell Trials
The Future of Regulatory Processes in Cell and Gene Therapy
FDA Regulations for CAR T-cell Therapy
Approaching Institutional Biosafety Committee Approval for CAR T-cell Therapy
Key Challenges within CAR T-cell Clinical Trials
The Mission Behind CAR T-cell Clinical Trials
Related Content
An Evolving ‘Opinion’ Landscape: New Paths—and Synergies—for Pharma KOLs & DOLs
October 13th 2023Article
Industry experts discuss the relationship between digital and traditional (key) opinion leaders and how companies are adjusting their strategies to harness the unique brand engagement benefits each role can provide in driving better patient outcomes.
